Home Core Services Funding Opportunities Research Membership Publications and Resources Contact

Study Profile:
Outreach and Methadone for Former Inmates (SAMHSA CSAT) (The MOD Study)

Revised:

December 5, 2006

Study Site:

The Miriam Hospital/Brown University School of Medicine

Study Name:

Outreach and Methadone for Former Inmates (SAMHSA CSAT) (The MOD Study)

Study Status:

Enrolling subjects

Principal Investigator:

Josiah Rich, MD, MPH

Years of Funding:

Sept. 2002 – Sept 2007

Study Aims:

The purpose of the project is to increase access to methadone for recently incarcerated heroin addicts in order to reduce recidivism, improve health, and increase personal stability; and to provide linkage to treatment and preventive services.

The Objectives are:

  • To set up an outreach program and a network of methadone maintenance providers for ex-offenders.
  • To enroll 120 formerly incarcerated persons in methadone maintenance therapy each year for 5 years (total enrolled = 600).
  • To provide linkage to testing and treatment services for co-morbid conditions of HIV/AIDS, hepatitis B and C, and mental illness.
  • To conduct the required federal data collection and a local evaluation, and disseminate the results of the program.

Study or Clinic Location

The Miriam Hospital; Rhode Island Department of Corrections; Methadone Treatment Facilities

# of Participants:

Goal:

120 per year totaling 600 over 5 years

Enrolled:

Still in start-up phase – 0 enrolled

Inclusion Criteria:

Eligible participants must be (1) incarcerated within the previous two years; (2) opiate dependent with active heroin use or heroin use during the month preceding incarceration; (3) age 18 years or older; (4) meet the requirements for entry into methadone maintenance (i.e., one year history of opiate dependence); (5) English-, Spanish- or Portuguese-speaking; (5) plan to remain in Rhode Island for 12 months; (6) able to give informed consent.

Exclusion Criteria:

 

Definition of Drug Use

Opiate addicted for at least one year

Participant Characteristics:

% Female:

N=200 (33%)

% HIV+

No projected number of HIV+, though we will enroll participants at the Immunology Center

% DU (IDU or non-IDU)

100%

Study Domains:

Evaluation Outcomes

  • time from referral (discharge) to enrollment in methadone treatment
  • duration on methadone treatment
  • ongoing drug use while on methadone treatment (mandatory urine drug testing while in methadone treatment facility)
  • recidivism (self-report and confirmed with the Department of Corrections)
  • quality of life

Data collection instruments:

Eligibility Screen; Government Performance and Reporting Act tool (mandated by funder) and the Addiction Severity Index both administered at baseline, 6 and 12 months Chart abstraction forms for methadone clinics (methadone dose; toxicity screen; lab work; counseling attendance; program status) and abstraction of prison records – recidivism and charge

 

 

Home Core Services Funding Opportunities Research Membership Publications and Resources Contact